GV-971

Sodium oligomannate · Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GV-971, covering 2018-10-10 to 2025-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) [Phase 4]